Your search returned 2 results.

Results
	1.	MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma. [electronic resource] by Sadones, J Michotte, A Veld, P Chaskis, C Sciot, R Menten, J Joossens, E J R Strauven, T D'Hondt, L A Sartenaer, D Califice, S F E H Bierau, K Svensson, C De Grève, J Neyns, B Producer: 20090128 In: European journal of cancer (Oxford, England : 1990) vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers. [electronic resource] by Seront, E Rottey, S Sautois, B Kerger, J D'Hondt, L A Verschaeve, V Canon, J-L Dopchie, C Vandenbulcke, J M Whenham, N Goeminne, J C Clausse, M Verhoeven, D Glorieux, P Branders, S Dupont, P Schoonjans, J Feron, O Machiels, J-P Producer: 20130329 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search